MDMA-Assisted Therapy for PTSD: In conversation with Rick Doblin & Payton Nyquvest
Why is real world evidence important for psychedelic research and how do therapy and psychedelics wo
Read More
Numinus Announces Health Canada Approval of MAPS-Sponsored Open Label Study for MDMA-Assisted Therapy for PTSD
Real-world study expands access to MDMA-assisted therapy for patients with PTSD and concurrent disor
Read More
Numinus builds on strong MAPS Phase 3 trial results through Compassionate Access Trial of MDMA for PTSD
[embed]https://youtu.be/sCIzz2rZGCI[/embed] Yesterday, MAPS announced significant, positive resul
Read More
Numinus Congratulates MAPS on Phase 3 Clinical Trial of MDMA for severe PTSD
[embed]https://www.youtube.com/watch?v=p2YxSIpuTks[/embed] 1 in 11 Canadians will suffer from PTS
Read More
Numinus Congratulates MAPS on Phase 3 Clinical Trial Demonstrating Significant Benefits of MDMA-Assisted Therapy for Severe PTSD
Cliquez ici pour la version française Numinus and Multidisciplinary Association for Psychedelic
Read More
Numinus Wellness’s trial for MDMA-assisted therapy is in pre-implementation stage
The study, which is in collaboration with MAPS Public Benefit Corporation (MAPS PBC), subsidiary of
Read More
Numinus announces milestones in compassionate access trial for MDMA-assisted therapy in collaboration with MAPS Public Benefit Corporation
Cliquez ici pour la version française Trial enters pre-implementation stage having met several k
Read More Numinus Wellness Announces National Expansion with Acquisition of Montreal-Based Mindspace Wellbeing, a Full-service Well-being Organization and Pioneer in Psychedelic Programming
Cliquez ici pour la version française The combination further enhances Numinus’ leadership pos
Read More Numinus Wellness commends Health Canada for its intent to make MDMA and psilocybin treatment available through the Special Access Programme
First-of-its-kind policy amendment will allow legal access to evidence-based treatments to those in
Read More
Numinus and MAPS to Collaborate on MDMA Trial for PTSD
Vancouver-based firm Numinus announced yesterday it will collaborate with an arm of a longstanding n
Read More
“Buried by Puppies Licking Your Face” (Canadian Firms Champion MDMA for PTSD)
Numinus Wellness Inc. and Multidisciplinary Association for Psychedelic Studies Public Benefit Cor
Read More Numinus and MAPS Public Benefit Corporation announce collaboration agreement to seek approval of MDMA-assisted psychotherapy for PTSD single-arm, open-label trial
First-of-its-kind trial in Canada will pave the way for expanded MDMA-assisted treatment to support
Read More
